About Veradermics, Incorporated (MANE)

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

MANE trading today

MANE has traded between $133.92 and $147.54 in the current session, a range of $13.62. The latest price of $135.29 sits near the bottom of that range (10% of the way from low to high). The volume-weighted average price is $138.02, and the stock is trading below it. Traders often use VWAP as a gauge of whether buyers or sellers have had the better average entry today.

Where MANE holders stand

StockMarketLoop's Market Position model estimates how the shares traded between 2026-08-15 and 2026-11-13 were bought. Its estimate of the average cost basis is $125.42; at $135.29 the stock trades 7.9% above that level. About 68.8% of those shares are estimated to be held at a profit at the current price. A majority in profit means most recent buyers are in the green: fewer trapped holders overhead, but also more people with gains who might sell. The densest nearby clusters of cost basis sit around $135.17 (support) and $138.31 (resistance). Roughly 70% of the estimated cost basis lies between $108.47 and $141.97, and 90% between $100.09 and $148.25.

This is a model estimate built from price and volume history, not a record of actual positions.

How to read this page

Quote figures come from StockMarketLoop's market data feed and may be delayed; the timestamp in the summary above shows when they were observed. Company details come from public reference data. The cost-basis section is a statistical model, not a forecast. Nothing here is investment advice; see our financial disclaimer and editorial policy.